A proportion of patients with prostate cancer develop local, regional or distant recurrence after curative local treatment, which is increasingly detected due to novel imaging modalities such as choline or PSMA PET-CT [1, 3]. This evidence concerns the gene FOLH1 and Familial prostate cancer.